Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Nearly two-thirds of Canadian adults are overweight or living with obesity, but cost has historically been a major barrier to accessing weight-loss drug treatment in the country
Patients taking Wegovy have nearly five times the risk of sudden sight loss of those on Ozempic, a large-scale study has found
Just one
Di Paola, R
Many patients can switch from semaglutide to tirzepatide under medical supervision because tirzepatide targets multiple hormone pathways that support appetite and blood sugar control
US$ 22.30
US$ 22.57
US$ 27.65
